Predict and prevent disease better than ever before
CLINT™ Clinical Intelligence platform to improve access of diagnostics and therapies to the right patients
Our work in collaboration with the Reagan-Udall Foundation for the FDA showed a 91% predictive power for stroke on COVID patients
CLINT enables the design of the best trial with the optimal cohorts, accelerates recruitment of those patients into your study, accelerates product adoption through real-time RWD insights and improves drug utilization through identifying & closing care gaps.
To demonstrate the ability of CLINT™ platform to leverage RWD, generate ECAs and unlock the potential of clinical RWD, we replicated a large scale randomized clinical trial.
We worked in collaboration with Janssen Pharmaceuticals utilizing CLINT™ platform to analyze the EHR data of several million patients in the US with Type 2 Diabetes and track progression to Diabetic Kidney Disease (DKD).